Novartis Willful Patent Infringement Claims Dismissed In New York

(October 26, 2018, 12:56 PM EDT) -- NEW YORK — A New York federal judge on Oct. 24 found that allegations of willful infringement levied in connection with patented gene expression technology fail to state a claim (Novartis...
To view the full article, register now.